DE69226877D1 - Behandlung der hiv-assoziierten immun-thrombopenie purpura - Google Patents

Behandlung der hiv-assoziierten immun-thrombopenie purpura

Info

Publication number
DE69226877D1
DE69226877D1 DE69226877T DE69226877T DE69226877D1 DE 69226877 D1 DE69226877 D1 DE 69226877D1 DE 69226877 T DE69226877 T DE 69226877T DE 69226877 T DE69226877 T DE 69226877T DE 69226877 D1 DE69226877 D1 DE 69226877D1
Authority
DE
Germany
Prior art keywords
hiv
treatment
purpura
thrombopenie
associated immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69226877T
Other languages
English (en)
Other versions
DE69226877T2 (de
Inventor
Arthur Ammann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DE69226877D1 publication Critical patent/DE69226877D1/de
Application granted granted Critical
Publication of DE69226877T2 publication Critical patent/DE69226877T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69226877T 1991-05-31 1992-04-15 Behandlung der hiv-assoziierten immun-thrombopenie purpura Expired - Fee Related DE69226877T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70900691A 1991-05-31 1991-05-31
PCT/US1992/003138 WO1992021755A1 (en) 1991-05-31 1992-04-15 Treatment of hiv-associated immune thrombocytopenic purpura

Publications (2)

Publication Number Publication Date
DE69226877D1 true DE69226877D1 (de) 1998-10-08
DE69226877T2 DE69226877T2 (de) 1999-03-11

Family

ID=24848090

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69226877T Expired - Fee Related DE69226877T2 (de) 1991-05-31 1992-04-15 Behandlung der hiv-assoziierten immun-thrombopenie purpura

Country Status (9)

Country Link
US (1) US5605689A (de)
EP (1) EP0636173B1 (de)
JP (1) JPH06508133A (de)
AT (1) ATE170559T1 (de)
AU (1) AU651228B2 (de)
CA (1) CA2108580A1 (de)
DE (1) DE69226877T2 (de)
DK (1) DK0636173T3 (de)
WO (1) WO1992021755A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB9022543D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Antibody production
SK782002A3 (en) 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
AU2008200400B2 (en) * 2001-01-17 2012-06-07 Aptevo Research And Development Llc Binding domain-immunoglobulin fusion proteins
CN101684158A (zh) * 2001-01-17 2010-03-31 特鲁比昂药品公司 结合域-免疫球蛋白融合蛋白
US7754208B2 (en) 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
US20030133939A1 (en) 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
US7829084B2 (en) 2001-01-17 2010-11-09 Trubion Pharmaceuticals, Inc. Binding constructs and methods for use thereof
US20100268658A1 (en) * 2001-05-14 2010-10-21 Prolacta Bioscience Method for collecting, testing and distributing milk
US20020182243A1 (en) * 2001-05-14 2002-12-05 Medo Elena Maria Method of producing nutritional products from human milk tissue and compositions thereof
WO2003040311A2 (en) 2001-10-25 2003-05-15 The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4
US6707888B1 (en) * 2002-05-06 2004-03-16 Sprint Communications Company, L.P. Location evaluation for callers that place emergency telephone calls over packet networks
EP3552627A1 (de) * 2003-05-06 2019-10-16 Bioverativ Therapeutics Inc. Chimäre proteine mit gerinnungsfaktor fc zur behandlung von hämophilie
AU2004238263A1 (en) * 2003-05-06 2004-11-25 Syntonix Pharmaceuticals, Inc. Inhibition of drug binding to serum albumin
US7348004B2 (en) * 2003-05-06 2008-03-25 Syntonix Pharmaceuticals, Inc. Immunoglobulin chimeric monomer-dimer hybrids
TWI353991B (en) 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
US7754209B2 (en) 2003-07-26 2010-07-13 Trubion Pharmaceuticals Binding constructs and methods for use thereof
ES2460517T3 (es) 2005-07-25 2014-05-13 Emergent Product Development Seattle, Llc Reducción de células b mediante el uso de moléculas de unión específica a cd37 y de unión específica a cd20
BRPI0616323A2 (pt) 2005-09-20 2011-06-14 Prolacta Bioscience Inc mÉtodo para determinar se um fluido mamÁrio doado foi obtido a partir de um indivÍduo especÍfico
KR101571027B1 (ko) 2006-06-12 2015-11-23 이머전트 프로덕트 디벨롭먼트 시애틀, 엘엘씨 효과기 기능을 갖는 단일쇄 다가 결합 단백질
CA2706722C (en) * 2006-11-29 2016-01-12 Prolacta Bioscience, Inc. Human milk compositions and methods of making and using same
US8377445B2 (en) * 2006-12-08 2013-02-19 Prolacta Bioscience, Inc. Compositions of human lipids and methods of making and using same
CN102099377A (zh) 2008-04-11 2011-06-15 新兴产品开发西雅图有限公司 Cd37免疫治疗剂及其与双功能化学治疗剂的联合
CN102300575A (zh) 2008-12-02 2011-12-28 普罗莱克塔生物科学公司 人乳渗透物组合物及其制备和使用方法
DK2739157T3 (en) 2011-08-03 2018-01-08 Prolacta Bioscience Inc Microfiltration of human milk to reduce bacterial contamination
MX2015012205A (es) 2013-03-13 2016-05-26 Prolacta Bioscience Inc Productos de leche humana altos en grasa.
TWI788044B (zh) 2013-03-15 2022-12-21 美商百歐維拉提夫治療公司 因子ｉｘ多肽調配物
CA2999138C (en) 2015-09-21 2024-05-21 Aptevo Research And Development Llc Cd3 binding polypeptides
CA3009667C (en) 2015-12-30 2024-03-26 Prolacta Bioscience, Inc. Human milk products useful in pre- and post-operative care

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226414A (en) * 1987-10-02 1992-07-28 Genentech Inc Cd4 peptide adhesion variants and their preparation and use
US5336603A (en) * 1987-10-02 1994-08-09 Genentech, Inc. CD4 adheson variants
PT89484B (pt) * 1988-01-22 1994-03-31 Gen Hospital Corp Genes clonados codificadores de proteinas de fusao ig-cd4 e sua utilizacao
WO1990000617A1 (en) * 1988-07-06 1990-01-25 Bio-Research Laboratories, Inc. Antibodies specific towards gp 48
IL91386A0 (en) * 1988-08-24 1990-04-29 Boehringer Ingelheim Kg Method for treating autoimmune diseases by using a paf antagonist and pharmaceutical compositions comprising it
CA2011299A1 (en) * 1989-03-03 1990-09-03 Franklin Volvovitz Aids therapy
WO1990012108A1 (en) * 1989-04-03 1990-10-18 Genetics Institute, Inc. Megakaryocyte growth promoting activity
EP0394827A1 (de) * 1989-04-26 1990-10-31 F. Hoffmann-La Roche Ag Chimärische CD4-Immunoglobulin-Polypeptide

Also Published As

Publication number Publication date
EP0636173A1 (de) 1995-02-01
DK0636173T3 (da) 1999-05-31
WO1992021755A1 (en) 1992-12-10
US5605689A (en) 1997-02-25
JPH06508133A (ja) 1994-09-14
AU651228B2 (en) 1994-07-14
CA2108580A1 (en) 1992-12-01
AU2003192A (en) 1993-01-08
ATE170559T1 (de) 1998-09-15
EP0636173B1 (de) 1998-09-02
DE69226877T2 (de) 1999-03-11

Similar Documents

Publication Publication Date Title
DE69226877D1 (de) Behandlung der hiv-assoziierten immun-thrombopenie purpura
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
DK1175909T3 (da) Terapeutiske sammensætninger af antistoffer og antisense-nukleinsyrer mod Serrate
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
ATE219373T1 (de) Medikamente zur behandlung von autoimmunerkrankungen mit interferon-tau
ATE32728T1 (de) Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel.
DE69331758D1 (de) Fibrinogen-bildungsprotein
DE69410254T2 (de) Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
DE69009684T2 (de) Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler Störungen.
ATE100714T1 (de) Arzneimittel (calcitoningen verwandte peptide) zur behandlung erektiler dysfunktionen.
DK384084A (da) Vaeksthormonfrigoerende peptider samt fremgangsmaade til behandling af pattedyr hermed
DK241287A (da) Anvendelse af glutamin til fremstilling af et laegemiddel til behandling af kataboliske forstyrrelser
ATE9437T1 (de) Pharmazeutisches mittel zur heilung von entzuendlichen und/oder degenerativen und/oder atrophischen schleimhauterkrankungen.
ATE81004T1 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
DK482185A (da) Peptider, deres fremstilling og anvendelse som laegemidler
ATE251631T1 (de) Dipohosphonsäuresalze für die behandlung von osteoporose
NZ231320A (en) Aqueous oral preparations of diclofenac
ATE114468T1 (de) Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs.
DE3162674D1 (en) A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
DE3879837T2 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
TH21704B (th) เพพไทด์ชนิดใหม่ที่มีผลปรับภูมิคุ้มกัน
EP0147194A3 (en) Method and compositions for treating cerebral ischemia

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee